Skip to main content
Log in

Epoetin-α: no QOL benefits in patients with solid tumours

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Christodoulou C, Dafni U, Aravantinos G, Koutras A, Samantas E, Karina M, Janinis J, Papakostas P, Skarlos D, Kalofonos HP, Fountzilas G.Effects of epoetin-alpha on quality of life of cancer patients with soild tumors receiving chemotherapy. Anticancer Research 29: 693-702, No. 2, Feb 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epoetin-α: no QOL benefits in patients with solid tumours. Pharmacoecon. Outcomes News 574, 9 (2009). https://doi.org/10.2165/00151234-200905740-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905740-00023

Keywords

Navigation